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Abstract
Background: Given the usefulness of rats as an experimental system, an efficient method for generating rat induced
pluripotent stem (iPS) cells would provide researchers with a powerful tool for studying human physiology and disease.
Here, we report direct reprogramming of rat neural precursor (NP) cells and rat embryonic fibroblasts (REF) into iPS cells by
retroviral transduction using either three (Oct3/4, Sox2, and Klf4), four (Oct3/4, Sox2, Klf4, and c-Myc), or five (Oct3/4, Sox2,
Klf4, c-Myc, and Nanog) genes.
Methodology and Principal Findings: iPS cells were generated from both NP and REF using only three (Oct3/4, Sox2, and
Klf4)geneswithoutc-Myc.Twofactorswerefoundtobecriticalfor efficient derivationandmaintenanceofratiPScells:the use
of rat instead of mouse feeders, and the use of small molecules specifically inhibiting mitogen-activated protein kinase and
glycogen synthase kinase 3 pathways. In contrast, introduction of embryonic stem cell (ESC) extracts induced partial
reprogramming,butfailedtogenerateiPScells.However,whencombinedwithretroviraltransduction,thismethodgenerated
iPS cells with significantly higher efficiency. Morphology, gene expression, and epigenetic status confirmed that these rat iPS
cells exhibitedESC-like properties,includingthe ability to differentiate into all three germ layersboth invitro and interatomas.
In particular, we found that these rat iPS cells could differentiate to midbrain-like dopamine neurons with a high efficiency.
Conclusions/Significance: Given the usefulness of rats as an experimental system, our optimized method would be useful
for generating rat iPS cells from diverse tissues and provide researchers with a powerful tool for studying human physiology
and disease.
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Introduction
The cloning of Dolly the Sheep over a decade ago demonstrated
that adult somatic cells could reprogrammed back to a state of
pluripotency [1]. In 2006, Yamanaka and his colleagues showed
that retroviral transduction of four transcription factors (Oct4,
Sox2, Klf4 and c-Myc) could also induce pluripotency in
mammalian (mouse) cells [2]. Subsequent studies demonstrated
that human induced pluripotent stem (hiPS) cells could be
generated using the same or slightly different sets of reprogram-
ming factors, offering the possibility to generate disease- or patient-
specific stem cells [3,4,5,6,7,8,9,10].
The rat animal model is one of most valuable models for the
study of numerous human diseases as well as for therapeutics
development. For instance, 6-OHDA lesioned rats is one of most
popular animal model for Parkinson’s disease (PD) [11,12,13].
Notably, however, its biological and biomedical study is limited
because the generation of transgenic rats by targeted gene
manipulation is not yet established. Recently, three groups
reported the establishments of chimera- and/or germline-compe-
tent ESCs from rat blastocysts [14,15,16], strongly suggesting that
it will be possible to generate transgenic rats by targeted gene
manipulation in the near future. In addition, two groups recently
reported generation of iPS cells from rat liver progenitor cells [17]
or primary ear fibroblasts and bone marrow cells [18].
In this study, we sought to establish an efficient procedure to
generate iPS cells from two different rat tissues, neural precursors
(NPs) and rat embryonic fibroblast (REF), by introducing total
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transcription factors. We found that introduction of ESC-extracts
into rat NP cells failed to generate iPS cells inducing only partial
reprogramming. However, rat iPS cells were successfully generated
from both NPs and REF by retroviral transduction of reprogram-
ming factors with or without c-Myc, and the efficiency was
significantly improved when these two methods were combined.
Notably, we established an optimal procedure to generate and
maintain rat iPS cells by culturing the cells on REF instead of mouse
embryonic fibroblast(MEF) as the feeder inthe presenceof mitogen-
activated protein kinase kinase (MEK) and glycogen synthase kinase
3( G S K 3 b) inhibitors (PD0325901 and CHIR99021, respectively).
Rat iPS cells derived from our optimized procedure exhibited ESC-
like properties by morphological, gene expression, epigenetic status,
proliferation, and differentiation criteria. In particular, we show that
these rat iPS cells can efficiently differentiate to multiple neuronal
lineages including midbrain-like dopaminergic neurons which will
serve as invaluable platform for bioassay and cell transplantation
studies of PD.
Materials and Methods
Cell Culture
We employed neural precursor (NP) cell culture from micro-
dissected cortices from rat embryonic day 14 (day of concep-
tion=day 0). Time-pregnant Sprague-Dawley (SD) rats were
purchased from Charles River Laboratories. INC. (Wilmington,
MA). All animal procedures were performed in accordance with
National Institute of Health guidelines and were approved by the
Animal Care and Use Committee (IACUC) at McLean Hospital,
Harvard Medical School.
Embryonic cortices were dissected from rat embryos and
mechanically dissociated in Ca
2+/Mg
2+-free Hank’s balanced salt
solution (CMF-HBSS). Cells were plated at 8000 cells/cm
2 on
10 cm tissue culture dishes pre-coated with poly-L-ornithine
(PLO; 15 mg/ml) at 37uC two hours followed by fibronectin
(FN; 1 mg/ml) overnight. NPs were allowed to proliferate in the
presence of 20 ng/ml basic fibroblast growth factor (bFGF; R&D
Systems, Minneapolis, MN) in serum-free medium (N2) for 4–6
days [19,20]. For rat embryonic fibroblast (REF) isolation, uteri
isolated from 14-day-pregnant SD rats were washed with
phosphate-buffered saline (PBS). The head and visceral tissues
were removed from isolated embryos. The remaining bodies were
washed in fresh PBS, transferred into a 0.1 mM trypsin/1 mM
EDTA solution, and incubated for 20 min. After incubation, REF
culture medium (DMEM containing 15% defined FBS) was added
and cells were dissociated by pipetting. We used REFs at passage
two for reprogramming experiments and for feeders. For mouse
embryonic fibroblast (MEF) cells, 13-day-pregnant CD1 mice
were used under the same isolation and culture methods.
Induced pluripotent stem (iPS) cells were generated and
maintained in ES medium, Dulbecco’s modified Minimal Essential
Medium (DMEM, Invitrogen, Carlsbad, CA), supplemented with
2mM L-glutamine (Invitrogen, Carlsbad, CA). 1mM b-mercapto-
ethanol, 1x non-essential amino acids (NEAA; Invitrogen,
Carlsbad, CA), 15% fetal bovine serum (FBS, Sigma-Aldrich, St.
Louis, MO), 100 U/ml penicillin, 100 mg/ml streptomycin
(Invitrogen) and 2000 U/ml leukemia inhibitory factor (LIF;
Chemicon, Termecula, CA) supplemented with signal inhibitors,
CHIR99021 (3 mM; Axon Medchem, Groningen, Netherland)
and PD0325901 (0.5 mM; Axon Medchem). IPS cells were
maintained on feeder layers of mitomycin C (10 mg/ml media,
Sigma-Aldrich)-treated REF cells. For picking and passaging,
rat iPS cells were washed once with ES medium and then
mechanically picked (until passage 10) or incubated with 1 mg/ml
collagenase type IV (Stem cell Technology, INC., Vancouver,
Canada) for 10 min. An appropriate volume of the medium was
added, and the contents were transferred to a new dish on REF
feeder cells. The split ratio was 1:1 (until passage 5) and after
routinely 1:3. For feeder-free culture of iPS cells, the plate was
coated with gelatin (Stem cell Technology, INC.).
Making cell extracts and streptolysin O (SLO)-mediated
permeabilization and cell extract treatment
Mouse ESCs (J1) were propagated in vitro using feeder-free
conditions without signal inhibitor supplementation. ESC-extracts
were prepared when cultures reached 70–80% confluence. To
prepare ESC-extracts, cells were washed with PBS once followed
by one wash with cell lysis buffer (100 mM HEPES, pH 8.2,
50 mM NaCl, 5 mM MgCl2, 1 mM dithiothreitol, and protease
inhibitors), followed by sedimentation at 400 g, suspension in 1
volume of cold cell lysis buffer, and incubated for 30–45 min on
ice. Cells were sonicated. The supernatant was aliquoted, frozen
and stored at 280uC. Lysate from 10 million J1-ESCs was used to
generate 100 ml of extract. Control NP or pluripotent factors
infected NP cells were washed in cold PBS and in cold CMF-
HBSS. Cells were suspended in aliquots of 100,000 cells/100 mlo f
HBSS, and centrifuged at 2,500 g for 5 min at 4uC. Sedimented
cells were suspended in HBSS, and streptolysin-O (SLO; Sigma)
was added to a final concentration of 400 ng/ml. Permeabilization
was assessed by monitoring uptake of FITC-labeled F(ab’)2-
antibodies from a separate sample 24 h after resealing and
replating the cells. After permeabilization, cells were suspended at
1000 cells/ml in 100 ml of ESCs extract containing an ATP-
regenerating system (1 mM ATP, 10 mM creatine phosphate, and
25 mg/ml creatine kinase), 100 mM GTP (Sigma-Aldrich), and
1 mM each nucleotide triphosphate (NTP). The tube containing
cells was incubated horizontally for 1 h at 37uCi naC O 2-
incubator with occasional agitation. After dissociation, cells were
plated into gelatin-coated plates for clone formation with N2/ES
media (1:1 volume mixture) containing bFGF (1 ng/ml). To reseal
plasma membranes, we add 2 mM CaCl2 to the culture media.
Retroviral infection
The cDNA encoding hOct4, hSox2, hKlf4, hNanog and hc-
Myc (Open Biosystems) were subcloned into the pCL retroviral
expression vector [21]. The nucleotide sequences for the cloned
genes were confirmed by sequence analysis. Each recombinant
plasmid was introduced into the 293gpg retrovirus packaging cell
line [21] by transient transfection, followed by harvesting.
For viral transduction, NP or REFs cultured in vitro were
incubated with the viral supernatant containing polybrene
(hexadimethrine bromide; 1 mg/ml; Sigma) overnight. After
infection, cells were incubated six more days in ES culture media.
At day six of infection, cells were replated on REF-feeder plate
with or without ESC-extracts treatment.
RT-PCR analysis for marker genes
Total RNA was purified with Trizol reagent (Invitrogen), five
micrograms of total RNA were used for reverse transcription reaction
with SuperScript II (Invitrogen) and oligo-dT primer, according to
the manufacturer’s instructions. PCR reaction conditions were
optimized to determine the linear amplification range. Amplification
products were identified by size. Primer sequences were: glyceralde-
hyde-3-phosphate dehydrogenase (GAPDH)
(59-TGACATCAAGAAGGTGGTGAAGC-39,5 9-CCCTGT-
TGCTGTAGCCGTATTG-39); endogenous rat specific Oct4
Reprogramming of Rat NP & REF
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GAAAGGTTTCCCGCG-39); endogenous rat specific Nanog (59-
AGGGTCTGCTACTGAGATGCTCTG-39,5 9-AGGTCTGA-
CTGCCCCATACTGG-39); transgenic Oct4 (59-GAAGGAT-
GTGGTCCGAGTGT-39,5 9-CATCTGTTCTTGGCCCTGA-
G-39); transgenic Klf4 (59-CCCACACAGGTGAGAAACCT-39,
59-CATCTGTTCTTGGCCCTGAG-39); transgenic Sox2 (59-
TACCTCTTCCTCCCACTCCA-39,5 9-CATCTGTTCTTGG-
CCCTGAG-39); embryonic cell-activated transcpript 1 (Ecat1)
(59-AGGTCAACGAGGCTGCCA-39,5 9-GGGTCTCCCACT-
CAAAAACC-39); embryonic cell-specific gene 1 (ESG1) (59-
TCCAGAAGTATTCCAGGTCCA-39,5 9-CTCCAGGGTCT-
TCATGGATT-39); reduced expression 1 (REX1) (59-AGGA-
TGGCCGGAAGGAGAA-39,5 9-TGCCCGTCCACATTGTC-
TT-39); fibroblast growth factor 4 (FGF4) (59-CAGCGGGG-
CAGGGGACTA-39,5 9-CTTGGTCCGCCCGTTCTTAC-39);
forkhead box A2 (FOXA2) (59-GCAAGCAAGGAAGCCTA-
TCTT-39,5 9-GGTGCAGCACTGATCTACAA-39); Brachyury
(59-AGTACGAACCTCGGATTCAC-39,5 9-CTGAGACTTG-
TAGACAACTGG-39); and bIII-tubulin (Tuj1) (59-TGGAC-
AGTGTTCGGTCTGG-39,5 9-CCTCCGTATAGTGCCCTT-
TGG-39).
Alkaline phosphatase staining and
immunocytochemistry
Alkaline phosphatase (AP) staining was performed using the
Alkaline phosphatase staining kit II (Vector Vector Laboratories,
Burlingame, CA).
For immunocytochemistry, cells were fixed with 4% parafor-
maldehyde for 20 min at room temperature. After washing with
PBS, cells were treated with PBS containing 10% normal goat
serum and 0.1% Triton X-100 for 35 min at room temperature.
Primary antibodies included SSEA1 (monoclonal, 1:100, Devel-
opmental Studies Hybridoma Bank, Iowa, IA), Nanog (polyclonal,
1:300, Abcam, Cambridge, MA), Rex1 (polyclonal, 1:200,
Abcam), smooth muscle actin (SMA; monoclonal, 1:400, Dako,
Glostrop, Denmark), anti-bIII tubulin (Tuj1; monoclonal, 1:500,
Covance, Richmond, CA), GFAP (polyclonal, 1:500, DAKO),
Sox17 (monoclonal, 1:200, SantaCruz Biotech.), tyrosine hydrox-
ylase (TH; rabbit or sheep polyclonal,1:1,000, Pel-Freez, Rogers,
AR), serotonin (5-HT; polyclonal,1:2000, Sigma), GABA (poly-
clonal, 1:700, Sigma), choline acetyl transferase (ChAT; polyclon-
al, 1:700, Sigma), nestin (monoclonal, 1:1,000, BD Sciences,
Franklin Lakes, NJ), Ki67 (monoclonal, 1:500, Novocastra
laboratories Ltd., United Kingdom), Ptx3 (polyclonal, 1:200,
Zymed), Engrailed-1 (En-1; monoclonal, 1:100, Developmental
Studies Hybridoma Bank), collagen type I (monoclonal, 1:100,
Developmental Studies Hybridoma Bank), Fibronectin (monoclo-
nal, 1:5, Developmental Studies Hybridoma Bank). For detection
of primary antibodies, fluorescence-labeled (Alexa fluor 488 or
568; Molecular Probes, Eugene, OR) secondary antibodies were
used according to the specifications of the manufacturer. Cells
were mounted in Vectashield containing 49,6-diamidino-2-pheny-
lindole (DAPI; Vector Lab.) and analyzed under a fluorescent
microscope.
In vitro differentiation of iPS cells
Cells were harvested by trypsinization and transferred to
bacterial culture dishes in ES medium without LIF. Total RNA
derived from EB on day 4 was used for RT-PCR analysis. After 5
days, aggregated cells were plated onto tissue culture dishes and
incubated for another 8,10 days with serum-free ITSFn medium
[22]. These differentiated cells were stained with antibodies
specific for the three germ layers. For neural induction, the 5-
staged method [22] was used with simple modifications. Briefly,
iPS cells were dissociated and EBs were allowed to form for five
days after plating of iPS cells in bacterial dishes in ES medium
without LIF (EB media; stage 2). EBs were attached to tissue
culture dishes and neural precursor were then selected for by
incubation in serum-free ITSFn medium (DMEM/F12 media
containing apotransferrin (50 mg/ml), insulin (5 mg/ml), sodium
selenite (30 nM), fibronectin (250 ng/ml), 100 U/ml penicillin,
100 mg/ml streptomycin ) for 4–6 days (stage 3). Cells were
subsequently dissociated by trypsin (0.05%) and neuronal
precursors expanded and patterned for four days after plating
onto PLO/FN-coated plates at a density of 50,000 cells/cm2 in
DMEM/F-12 media with apotransferrin (100 mg/ml), insulin
(5 mg/ml), sodium selenite (30 nM), progesterone (20 nM),
putrescine (100 nM), 100 U/ml penicillin, 100 mg/ml streptomy-
cin, 1 mg/ml laminin (N3 media) with bFGF (20 ng/ml), at day 3,
Shh (500 ng/ml) and FGF8 (100 ng/ml ; all from R & D Systems)
were added (stage 4). The cells were subsequently differentiated in
N3 media with ascorbic acid (AA; 200 mM) for 7 days (stage 5).
Teratoma formation
Rat NP-iPS cells (#2 and #4) and RES-iPS cells (#3 and #4)
were suspended in DMEM containing 10% FBS. Nude mice were
anesthetized and the cell suspension was injected subcutaneously
into the kidney capsule. Four to six weeks after the injection,
tumors were surgically dissected from the mice. Samples were
weighed, fixed in PBS containing 4% formaldehyde, and
embedded in paraffin. Sections were stained with hematoxylin
and eosin.
Bisulfite genomic sequencing
Genomic DNA from cells was performed with the DNeasy
Tissue Kit (Qiagen, Valencia, CA). Bisulfite treatment was done
using the EpiTect Kit (Qiagen) following the manufacturer’s
instruction. Bisulfite treated DNA was amplified using primers
designed for methylation PCRs (http://www.urogene.org//
methprimer/index.html): the forward primer 59-AGT TTT
GAG GTG TTT AGG GAT TTA T-39 and reverse primer 59-
CCC CAC CAA ATA AAA ATA AAA AAA-39 for Oct4, and the
forward primer 59-GGG TTT GGT AGG AGG GAT TAA T-39
and reverse primer 59-TCA ACC TAT CTA AAA ACC AAC
AAC TC-39 for Nanog. For more products, semi-nested PCR was
performed using the forward primer 59-GAA AAT GAA GGT
TTA TTT GGT TGT-39 for Oct4 and 59-TTT GGT AGG AGG
GAT TAA TTG TG-39 for Nanog, respectively and in reverse as
above. The resulting amplified PCR products were gel-purified,
subcloned into the T vector (Promega, Madison, WI) and
sequenced.
Karyotyping analysis
Standard G-band chromosome analysis was performed by Cell
Line Genetics (Madison, WI).
Results and Discussion
Introduction of ESC-extracts into rat NPs resulted in
partial reprogramming but failed to generate iPS cells
Based on previous studies showing that fusion of ESCs with
somatic cells induce nuclear reprogramming [23,24,25], we
hypothesized that introduction of ESC total proteins into rat
somatic cells may reprogram them to a pluripotency. To address
this, we attempted to generate rat iPS cells by introducing total
ESC-extracts into permeabilized rat NP cells. Toward this goal,
we dissected NPs from E14 rat cortices and expanded them in the
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majority of these expanded NP cells (.98%) were positive for
nestin and the active mitotic marker Ki67 (Figure S1). 5610
4 NP
cells were treated with mouse ESC-extracts following streptolysin
O-mediated permeabilization. Fifteen days following ESC extract
treatment, approximately 10 colonies appeared, while no colonies
were observed in the absence of treatment or when treated with
293T cell extracts. These colonies were flat, adherent and non-
granulated (Figure S2a). When they were picked up and replated
onto mitomycin C-treated mouse embryonic fibroblast (MEF)
feeders, they did not exhibit large nucleoli and appeared different
from typical dense ESC-like morphology. Approximately 20% of
these clones expressed Nanog, but none of them expressed other
pluripotent markers such as Oct4 or were positive for alkaline
phosphatase (AP) (Figure S2b; data not shown). Following
maintenance under neural culture condition and in vitro
differentiation, these clones could generate neurons and astrocytes
(Figure S2c). In contrast, NP cells that were maintained without
ESC extract treatment mostly differentiated into astrocytes (Figure
S2c, d). Together, our results show that introduction of ESC-
extracts into permeabilized NP cells induced partial reprogram-
ming but failed to generate iPS cells.
Generation of ESC-like iPS cells from rat NPs and
fibroblasts
Next, we tested if retroviral transduction of the five (Oct4, Sox2,
Klf4, c-Myc, and Nanog: OSKMN) and/or four factors (OSKM)
could reprogram rat NPs and fibroblasts to generate iPS cells.
Monitoring infection efficiency with the GFP-expressing pCL-
retroviral vector, revealed that the majority of rat NPs (.95%)
could be transduced (data not shown). The time schedule for rat iPS
cell induction is summarized in Figure 1a. First, we examined the
formation of colonies after retroviral transduction to express the five
or four factors. Six days post retroviral transduction NPs were
Figure 1. Generation of iPS cells from rat neural precursor cells (rNP) and embryonic fibroblast cells (REF). (a) Schematic time schedule
of rat-iPS generation. (b) Clone formation after pluripotent factors induction with or without ESC-extract treatment. Shown are alkaline phosphatase
(AP)-positive clone numbers (black columns) from the total numbers of colony (white columns) at 20 days after transduction. (Each column from
n=14 of 6 independent experiments, error bars indicate S.E.; *OSKMN: Oct4, Sox2, Klf4, c-Myc, Nanog) (c) Colonies with ESC morphology could be
maintained in the presence of MEK inhibitor, PD0325901 (0.5 mM) and GSK3b inhibitor, CHIR99021 (3 mM) (right). Colonies under conventional ES
culture condition lost AP-positive character and kept differentiating (left). (d) Rat embryonic fibroblast (REF)-derived feeders are necessary for
maintaining ESC-like character. After several passages, ESC-like colonies lost AP activity on mouse embryonic fibroblast (MEF)-derived feeders
combined with 2 inhibitors, PD0325901 and CHIR99021. (e) Phase-contrast micrograph of rat embryonic NP and fibroblast (far left). Isolation of rNP-
iPS and REF-iPS cells based on morphology, pictures on the right show rNP-iPS #2 clone and REF-iPS #3 formation, respectively. P0 image shows the
representative clone formed at 20 days after infection (P0: passage 0) and image P1 was taken at 7 days after picking (passage 1). Examples of
homogeneous colonies from images on the left at passage number 10 (P10) and on the right at passage number 20 (P20).
doi:10.1371/journal.pone.0009838.g001
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titer of pCL empty virus or GFP-expressing virus was used for
transduction. Colonies started to appear from five and four factor-
transduced NPs at day 13 to 16 post-infection, but not from empty
vector-or GFP vector-transduced cells. These colonies were highly
proliferative and adopted a morphology distinct from those formed
by ESC extract treatment (Fig. 1c). Some of these clones exhibited
granulation and AP activity. We first tested if rat NP-derived ESC-
like colony formation is influenced by feeder variants, i.e., MEF vs.
rat embryonic fibroblast (REF) feeders. Interestingly, we found that
AP-positive colonies were generated with significantly higher
efficiency on REF than on MEF. For instance, 51 AP-positive
colonies (out of total 93 colonies) were formed from 5610
4 NPs by
treatment with 5 factors on REF, while 36 AP+ colonies (out of total
53colonies)wereformedonMEFfeeder(Figure S3).Inthecase of4
factors(OSKM)transfection, 43 AP-positive colonies(out of67 total
colonies) and 20 AP-positive (out of 34 total colonies) were formed
on REF and MEF, respectively. Approximately 20% of these AP-
positive colonies exhibited ESC-like morphology and approximate-
ly 40% of AP-positive clones were SSEA1 positive (Figure S4B; data
not shown).
We next tested whether retroviral transduction of 3 factors
(Oct4, Sox2, and Klf4: OSK) without c-Myc can also generate
ESC-like colonies. Although the efficiency was lower than 5 and 4
factors transduction, AP-positive ESC-like colonies could be
generated by 3 factors without c-Myc (Figure S3). Again, REF
was significantly better than MEF for generation of reprogrammed
colonies by 3 factors. Furthermore, we could generate ESC-like
colonies by 5, 4, and 3 factor transduction from REF cells as the
starting cells (Figure S4). Interestingly, similar to generation of
ESC-like colonies from NP cells, REF was significantly better than
MEF as feeder for generation of ESC-like colonies from REF (data
not shown). Thus, in this case, rat embryonic fibroblasts were used
as both starting cells and feeders for reprogramming.
Notably, these NP or REF-derived ESC-like colonies lost ESC-
like morphology and AP activity when maintained under
conventional murine ESC culture condition (Fig. 1c, left). Based
on recent studies showing that inhibition of differentiation
inducing signals is essential for derivation and establishment of
rat ESCs [14,15], we speculated that the same treatment may be
necessary for rat iPS cell maintenance. Indeed, we found that
treatment with MEK inhibitor (PD0325901; 0.5 mM) and GSK3b
inhibitor (CHIR99021; 3 mM) significantly improved the mainte-
nance of both NP- and REF-derived ESC-like cells for their
morphology and AP activity (Fig. 1c, right). Notably, even in the
presence of these two inhibitors, these NP or REF-derived ESC-
like cells subsequently differentiated and lost their ESC-like
morphology on MEF feeders (Fig. 1d), again emphasizing the
importance of REF as feeder cells.
Using our established procedure, we further tested if combina-
tion of retroviral transduction and ESC extract treatment can
improve the efficiency of reprogramming. Toward this end, NPs
were permeabilized and treated with ESC-extracts six days post
retroviral transduction (Fig. 1a). Interestingly, the efficiency to
generate AP-positive colonies was significantly higher (Fig. 1b).
When retroviral transduction was combined with ESC-extracts
treatment, the efficiency AP-positive colonies was .0.2%, in the
case of five factor transduction plus ESC extract treatment
(Fig. 1b). Notably, this combined treatment resulted in accordingly
enhanced generation of ES-like morphology clones (.2.5-fold);
while 9 ES-like colonies out of 48 AP+ clones were generated by
retroviral four factor transduction, 24 ES-like colonies out of 102
AP+ clones were formed by combined treatment of retroviral 4
factor transduction and ESC-extract treatment (data not shown).
Putative rat iPS cells exhibit ESC-like properties in
proliferation, gene expression of ESC markers, and
epigenetic status
For further analyses, we selected 11 iPS-like clones derived from
NP (5 by OSKMN, 3 by OSKM, and 3 by OSK) and 9 clones
derived from REF (3 by OSKMN, 2 by OSKM, and 4 by
OSK)(Fig. 1e). These clones formed tightly packed colonies and
exhibited morphology almost identical to that of murine ESCs,
characterized by large nucleoli, scant cytoplasm and round shape
(Fig. 2a). Among these clones, we cultured and propagated 4 NP-
derived clones (rNP-iPS#1-#3 by OSKMN and rNP-iPS#4b y
OSK) and 4 REF-derived clones (REF-iPS#1 by OSKMN, REF-
iPS#2 by OSKM, REF-iPS#3, #4 by OSK) in ESC media
supplemented with 2 inhibitors on REF feeders for more than 25
passages. During this process, ESC-like morphology and growth
characteristics were consistently maintained in all 8 clones. These
ESC-like morphological and proliferative properties have been
maintained for at least 5 months with normal karyotypes (Fig. 2c,
Figure S5). These results strongly suggest that stable rat iPS cell
lines can be generated from rat NPs and REFs by retroviral
transduction of 5 (OSKMN) and 4 (OSKM) factors, as well as 3
(OSK) factors without c-Myc. We next examined these iPS cell
lines’ ESC marker gene expression. Immunocytochemical analyses
showed that all eight clones expressed endogenous ESC-specific
markers such as AP, Nanog, the surface antigen SSEA-1 (Fig. 2b),
and reduced expression 1 (REX1) (Figure S6a and data not
shown). Furthermore, RT-PCR analysis revealed that these
iPS clones expressed all rat endogenous ESC markers tested,
including Oct4, Nanog, embryonic cell-activated transcript 1
(Ecat1), embryonic cell-specific gene 1 (ESG1), REX1, and
fibroblast growth factor 4 (FGF4) (Fig. 2d), further supporting
that these clones show marker gene expression pattern that is
indistinguishable from ESCs. We next tested whether the
exogenous retroviral transgenes are efficiently suppressed in these
iPS cells. As shown in Figure S6b, six rat iPS clones tested by semi-
quantitative PCR analyses using specific primers demonstrated
that exogenous transgenes are undetectable or only marginally
expressed while endogenous genes are robustly induced. These
observations strongly suggest that retroviral-coded genes are
efficiently suppressed in these rat iPS cells.
The above gene expression of ESC markers strongly suggests
that epigenetic reprogramming has occurred in these rNP-iPS and
REF-iPS cells. To address this possibility, we next investigated the
epigenetic status of the Oct4 and Nanog gene promoters in rat iPS
cells (Fig. 2e). In order to investigate the basic stable methylation
pattern in rat somatic cells, we analyzed the methylation status of
both loci by bisulfite sequencing. As shown in Fig. 2e, the
promoter regions of Oct4 and Nanog genes were densely
methylated in REF cells (93%), suggesting that their chromosomes
represent the differentiated stage. Then we further performed
bisulfite sequencing with genomic DNAs extracted from NPs and
rNP-iPS cells. Interestingly, we found that promoter regions of rat
Oct4 and Nanog were much less methylated in NP isolated from
E14 rat cortex (54% and 63%, respectively). In rNP-iPS#2 cells,
both promoter regions of the rat Oct 4 and Nanog genes were
almost completely demethylated (3.6% and 2.5%, respectively).
Rat iPS cells differentiate into all three germ layers both
in vitro and in vivo
To analyze the differentiation potential of these rat iPS cells in
vitro, we used floating culture to induce EBs. After suspension
culture, ball-shaped EB structures were generated from all rat-iPS
clones. We attached these EB-like structures to tissue culture plate
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Attached cells showed various types of morphologies, such as those
resembling neural cells, muscle cells, and definitive endodermal
cells (Fig. 3a). RT-PCR analysis confirmed that these differentiated
cells express mRNAs for forkhead box A2 (FOXA2, endoderm
marker), Brachyury (mesoderm marker), and bIII-tubulin (Tuj1,
ectoderm marker) (Figure S7a). In addition, immunocytochemistry
analyses identified cells positive for SRY-box containing gene 17
(SOX17, endoderm marker), a-smooth muscle actin (a-SMA,
mesoderm marker), Desmin (mesoderm marker), glial fibrillary
alkaline phospatase (GFAP, ectoderm marker) and Tuj1 (ectoderm
marker) (Fig. 3a, Figure S7b). Taken together, our gene expression
analyses and immunostaining assays of in vitro differentiated cells
demonstrate that all rNP-iPS and REF-iPS cell lines tested here
are pluripotent and are able to differentiate into all three germ
lineage cells in vitro.
To test in vivo pluripotency, we transplanted two rNP-iPS
clones (#2 and #4) and two REF-iPS clones (#3 and #4) into the
kidney capsule of nude mice. In all four cases, teratoma formation
was observed in the kidney capsule at four to six weeks after
injection (Fig. 3b, Figure S7c). These rat-iPS-derived teratoma
were further analyzed by histological examination and found to
contain all three germ layer tissues including pigment retinal
epithelium (ectoderm), epidermal tissues (ectoderm), neural tube
(ectoderm), cartilage (mesodermal), striated muscle (mesoderm),
adipose tissue (mesoderm), intestinal epithelium (endoderm),
respiratory epithelium (endoderm) and cornea-like epithelial
tissues (endoderm) (Fig. 3b, Figure S7c; data not shown).
Rat iPS cells can efficiently differentiate into
dopaminergic neurons in vitro
We examined the differentiation potential of rNP-iPS and REF-
iPS cells to specialized neural lineage cell types including
dopaminergic neuronal fate, based on the five stage in vitro
differentiation method [22] with minor modification (Fig. 4a). Six
days following withdrawal of the mitogen bFGF (at day 21 in
Fig. 4a), immunocytochemistry analysis demonstrated that these
rat iPS cells could differentiate into all neural lineage phenotypes,
as examined by specific markers for NPs (nestin), neurons (Tuj1),
or astrocytes (GFAP) (Fig. 4b). Various subtype neuronal markers
were detected for dopaminergic (tyrosine hydroxylase; TH),
serotonergic (5HT), GABAergic (GABA) and cholinergic neurons
(choline acetyltransferase; ChAT) (Fig. 4b, c). In particular, we
found that in vitro differentiation of REF-iPS#2 cells in the
presence of sonic hedgehog (SHH), FGF8, and ascorbic acid
resulted in high yields of neurons (81.962.8% of total cells) and
dopaminergic neurons (9.263.7% of neurons) (Fig. 4d). In
addition, we confirmed that other rat iPS clones (e.g., rNP-iPS
#4 and REF-iPS #2 and 3) also showed efficient in vitro
Figure 2. Rat neural precursor cell and fibroblast derived-iPS cells (rNP-iPS and REF-iPS) share ESC characters. (a) Representative high
magnified image of rat iPS cells grown on feeder. (b) Both rNP-iPS and REF-iPS cells exhibited strong alkaline phosphatase (AP) activity and were
homogeneously labeled with antibodies against SSEA1 (green) and Nanog (red). (c) No karyotypic abnormalities were observed in REF-iPS #2. (d) iPS
clones derived from rat neural precursor (rNP-iPS #1,#4) and fibroblast (REF-iPS #1,#4) express ESC markers. RT-PCR analysis of ES marker genes,
Oct4, Nanog, ECAT1, ESG1, FGF4 and REX1. Rat neural precursor cell (rNP) and rat embryonic fibroblast cells (REF) were used as negative control.
GAPDH was used as a loading control. (e) DNA methylation status upstream of Nanog and Oct4 in rat PC12, rat NP, and rNP-iPS clone (#2) using
sodium bisulfite sequencing. The top panel indicates the CpG dinucleotide position of the Nanog and OCT4 promoter regions and the numbers show
positions of CpGs relative to the translation start site. Each PCR product was subcloned and subjected to nucleotide sequencing analysis. Eight
representative sequenced clones are depicted by open (unmethylated) and filled (methylated) circles for each CpG site.
doi:10.1371/journal.pone.0009838.g002
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Furthermore, these TH-positive neurons appear to have midbrain
dopaminergic phenotype because they co-express midbrain-
specific transcription factors, Ptx3 and En-1 (Fig. 4c).
The rat animal model is a critical experimental system for
disease modeling, physiological, pharmacological, and behavioral
studies of human [26]. Availability of germ line competent rat ES
and iPS cells will greatly facilitate and expand the usefulness of the
rat animal model for biomedical and translational research. Here,
we established an efficient procedure to generate rat iPS cells from
primary rat tissues. Our results demonstrate that iPS cells can be
reliably generated without drug selection from primary rat tissues
(both NP and REF) by retroviral transduction of the five (Oct4,
Sox2, Klf4, c-Myc, and Nanog: OSKMN), four (OSKM), or three
(OSK) reprogramming factor genes.
Salient features of this study are as follows. First, our optimized
procedure generated multiple rat iPS clones from both NP and
embryonic fibroblasts with similar efficiencies without genetic
selection suggesting that it may be generally applicable to diverse
rat primary tissues. Second, as shown in recent studies to derive rat
Figure 3. In-vitro and in-vivo differentiation of rat fibroblast derived iPS cells (REF-iPS #2 and #3). (a) Embryoid body (EB) mediated in
vitro differentiation of rat iPS clones. Upper panel show phase contrast images of differentiated cells at 10 days after EB attachment. Definitive
endoderm-like (left), contracting muscle-like (middle) and neuronal-like (right) cells are shown. Immunocytochemical analysis for the three germ layer
differentiation was performed 10 days after EB attachment (Lower images). Sox17 (green, endodemal; left), smooth muscle actin (SMA, red,
mesodermal; middle) and Tuj1 (green, ectodermal; right). Nuclei were stained with DAPI (blue). (b) Hematoxylin and eosin staining of teratoma
derived from rFC-iPS cells (#2 and #3). Cells were transplanted into the kidney capsule of three SCID mice. A tumor developed from one injection
site. Images are from a teratoma containing intestinal epithelium, respiratory epithelium (both endodermal); cartilage, muscle (both mesodermal);
neural tube, epidermis (both ectodermal).
doi:10.1371/journal.pone.0009838.g003
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and GSK3b, with chemical inhibitors PD0325901 and
CHIR99021, was critical for stable maintenance of rat iPS clones.
In addition, LIF was also necessary for rat iPS cell maintenance;
rat iPS cells spontaneously differentiated without it even in
the presence of PD0325901 and CHIR99021. Third, we found
that REF cells were significantly superior to MEF for stable
maintenance of rat iPS clones. When maintained on MEF, rat iPS
cells significantly lost their ES-like morphology, even in the
presence of differentiation signal inhibitors, PD0325901 and
CHIR99021, and LIF. In contrast, rat iPS cells could be stably
maintained on REF feeders in the presence of two inhibitors and
LIF. Li et al. (2008) found that rat ESCs could be stably
maintained as adherent cells, without differentiation, when grown
on L cells derived from adult C3H/An mouse connective tissues. It
will be of great interest to know if rat ESCs can be stably
maintained on REFs. Given that both mouse and rat iPS cells are
shown to be stably maintained on feeder cells originated from the
same species, as shown in mouse [2] and rat iPS cells (this study), it
will be interesting to learn whether human iPS cells can also be
maintained on appropriate human feeder cells. Indeed, a recent
study by Yamanaka and his colleagues demonstrated that human
iPS cells can be established and maintained on isogenic parental
feeder layers [27]. Forth, our results demonstrate that multiple rat
iPS cell lines can be generated from both NP and embryonic
fibroblasts by three (OSK) genes without c-Myc although the
efficiency was approximately half of that by the four genes.
Previous work showed that four factor-derived mouse iPS cells can
cause tumor formation in chimeras and progeny mice upon
reactivation of c-Myc [28]. Furthermore, iPS cells derived without
c-Myc did not develop tumors, strongly suggesting that the
presence of c-Myc gene is a serious problem for their biomedical
and clinical application. Thus, our successful generation and
characterization of cMyc-free rat iPS cells may be important for
the future application of rat iPS cells. Fifth, we optimized and
established an in vitro differentiation procedure allowing efficient
in vitro neurogenesis such that the majority of the differentiated
cells become neurons (.80% of total cells) and midbrain-like
dopamine neurons can be produced from these rat iPS cells with
high efficiency (approximately 10% of total neurons).
Based on previous studies showing that somatic cell fusion with
ESCs induced epigenetic reprogramming of somatic chromosomes
[23,25,29], we also tested if it is possible to generate rat iPS
cells by introducing ESC-extracts after streptolysin O-mediated
Figure 4. Rat fibroblast derived-iPS cells (REF-iPS#2 cells) progressively induced into dopaminergic neurons. (a) Scheme of the rat iPS
differentiation method used to induce dopaminergic neurons from rat iPS cells. Bottom pictures (i,v) show representative image of each stage. (b)
The five-stage neuronal differentiation method induced diverse neural differentiation in rat iPS cells. Six days after withdrawal of the mitogen bFGF at
day 21 of the differentiation procedure, expression of nestin (b, left, red), Tuj1 (b, left, green; b, right, red) and GFAP (b, right, green) confirmed the
neural identity of the REF-iPS derived neural differentiation. (c) Diverse subtypic neurons are expressed during rat iPS derived neuronal induction.
Serotonergic (5-HT, red, left), GABAnergic (GABA, red, middle) or cholinergic (ChAT, red, right)/Tuj1 (green)-positive neurons were induced. Images
were taken from REF-iPS#2 derived neuronal cells at day 21. (d) Dopaminergic neuronal differentiation from rat iPS#2-derived neuronal induction at
day 21. Representative images of TH (red)/Tuj1 (green)-positive neurons derived from rat iPS cells (Inset, DAPI nuclear staining of the same field). The
bottom table shows dopaminergic neuronal differentiation efficiency of rat fibroblast derived iPS cells (REF-iPS #2; from nine independent
experiments, mean 6 S.E). Indicated are the percent of neuronal (Tuj1+) cells per total (DAPI) cells or dopaminergic (TH+) cells per neurons (Tuj1+)a t
neuronal induction day 21.
doi:10.1371/journal.pone.0009838.g004
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cells as indicated by colony formation, Nanog expression in some
colonies, and more potent neural differentiation, compared to
non-treated cells (Figure S2). However, we failed to generate iPS
colonies by this method. Compared to the in vivo cell fusion
approach, our in vitro procedure may allow very limited amount
of proteins to be transported inside cells, resulting in only partial
reprogramming. Interestingly, the combination of ESC-extract
treatment and retroviral transduction of reprogramming factors
significantly increased the efficiency of generation of iPS-like
colonies, indicating that at least some reprogramming factors may
be transported into cells in their active forms.
Taken together, our results demonstrate that AP-positive
colonies can be efficiently generated from NP and REF cells
(approximately 0.2%) and approximately 20% of them became
iPS-like colonies with the ESC morphology. Using our optimized
procedure, we established 20 rat iPS clones (11 from NP and 9
from REF) and extensively characterized 4 NP-derived and 4
REF-derived clones in this study. Among them, three iPS clones
(rNP-iPS#4, REF-iPS#3 and #4) were generated without c-Myc.
All eight clones exhibited the molecular and cellular properties of
fully reprogrammed iPS cells such as ESC-like morphology, cell
proliferation, endogenous gene expression patterns, epigenetic
status, in vitro and in vivo pluripotency. These clones were stably
maintained for at least 25 passages with normal karyotype. Thus,
our results strongly suggest that ESC-like iPS cells can be derived
from genetically unmodified rat tissues including NPcells and
fibroblasts. We previously presented some results of this study
[30,31]. While this work was in progress, two groups reported
successful generation of rat iPS clones using significantly different
procedures. Liao et al. (2009) reported derivation of rat iPS cells
from primary ear fibroblasts and bone marrow cells by
introduction of the four factors (OSMK). Notably, these iPS cells
could be generated and maintained without differentiation signal
inhibitors and LIF, which is quite different from our results. One
possible explanation is that these rat iPS cells may have different
cellular properties because they are generated by lentiviral
transduction. Consistent with this possibility, this study reported
that iPS cells could not be generated by retroviral transduction. In
addition, Li et al. (2009) established rat iPS cell lines from a liver
progenitor cell line, WB-F344, by retroviral transduction of the
same four factors. Similar to our results, this study showed that
differentiation signal inhibitors, PD0325901 and CHIR99021, and
LIF are essential for the maintenance of rat iPS cells. Taken
together with these rat iPS cell derivation reports, our results
demonstrate that iPS cells can be efficiently generated and
maintained from genetically unmodified various rat tissues with
different sets of factors. These rat iPS clones will provide useful
research tools to study rat developmental biology and rat-based
models of various human diseases such as 6OHDA-lesioned rat
model of PD.
Supporting Information
Figure S1 Neural precursor (NP) cells isolated from rat E14
cortices are homologous cell populations and are actively mitotic.
NP cells were plated at 10,000 cells/cm
2 and expanded 3 days
with bFGF (20 ng/ml) prior to immunocytochemical analyses.
Left, a representative image of cells that are mostly positive for
nestin (NP marker; red). Only a minor fraction of cells (typically
,2%) are positive for TuJ1 (neuronal marker; green). Right,
nestin-positive NP cells (green) were double labeled with the
proliferation marker, Ki67 (red).
Found at: doi:10.1371/journal.pone.0009838.s001 (0.22 MB TIF)
Figure S2 Analysis of clones obtained from cortical NP cells by
treatment with ESC-extracts. (a) Representative morphology of
clones that are obtained at 2 weeks after treatment with ESC-
extracts (right) and untreated NP cells (left). (b) RT-PCR analysis of
mRNAs isolated from clones that are generated by treatment with
ESC extracts and untreated controls. Some of these clones
(approximately 20%) expressed Nanog, but none of them expressed
Oct4.(c,d)Differentiationpotentialofthesepartiallyreprogrammed
clones. NP cells without ESC treatment became almost completely
astrogenic and only differentiated to astrocytes (c, left). In contrast,
most clones obtained from ESC-extracts treated NPs, differentiated
to astrocytes and neurons with comparable efficiencies (c, right).
Differentiated cells were analyzed by immunostaining with anti-
bodies against the neuronal marker, Tuj1 (green) and astrocytic
marker, GFAP (red). Quantitative analyses of the differentiation
potential of clones obtained from treatment with ESC-extracts (d).
Results are presented as the mean 6 SEM of % GFAP+ and TuJ1+
cells in the total cell population. (n=15 from three independent
experiments, *P,0.001).
Found at: doi:10.1371/journal.pone.0009838.s002 (0.38 MB TIF)
Figure S3 Efficiencies of colony formation by feeder variants.
Rat NP-derived ESC-like colony formation is influenced by feeder
variants, i.e., mouse embryonic fibroblast (MEF) vs. rat embryonic
fibroblast (REF) feeders after treatment with the five, four or three
factors. Twenty-days post retroviral transduction analysis showing
alkaline phosphatase (AP)-positive clones, on MEF (white) and
REF (black) feeder (*P,0.001).
Found at: doi:10.1371/journal.pone.0009838.s003 (0.05 MB TIF)
Figure S4 (a) Efficiencies of colony formation after treatment
with the five, four or three factors from fibroblasts (REF) and
neural precursor cells (NP). Twenty-days post retroviral transduc-
tion analysis showing alkaline phosphatase (AP)-positive clones, in
black and the total numbers of colonies in white. (Each column
from n=12 (FC) or 14 (NSC) of 6 independent experiments, error
bars indicate S.E.) (b) Efficiencies of AP-positive clones (black bar)
and SSEA1 and AP double positive clones (patterned bar). These
clones are derived from 50,000 NPs by treatment with 4 factors
(O,S,K,M) or 3 factors (O,S,K) at 20 days post transduction.
Found at: doi:10.1371/journal.pone.0009838.s004 (0.06 MB TIF)
Figure S5 Karyotypic analysis of rat neural precursor cells
derived iPS clone #4. No karyotypic abnormalities were observed.
Found at: doi:10.1371/journal.pone.0009838.s005 (0.09 MB TIF)
Figure S6 (a) Representative image of REF-iPS cells exhibited
strong Rex1 (red; middle) activity. (b) Semi-quantitive RT-PCR
analysis of endogenous (endo-) and transgenic (trans-) retroviral
Oct4, Klf4 and Sox2 expressions in rat-iPS clones derived from rat
neural precursor (rNP-iPS #1, 2 and 4) and fibroblast (REF-iPS
#1, 3 and 4). All lines were at passage 10,14. Expression of
endogenous ES marker gene, Rex1, was used as control.
Found at: doi:10.1371/journal.pone.0009838.s006 (0.17 MB TIF)
Figure S7 In-vitro and in-vivo differentiation of rNP-iPS clones
(#1,#4). (a) RT-PCR analysis of embryoid bodies (EBs) for three
germ layer differentiation markers, endoderm (Foxa2), mesoderm
(Brachyury) and ectoderm (bIII-tubulin, Tuj1). (b) Immunocyto-
chemical analysis for differentiation to the three germ layer was
performed 10 days after EB attachment. Sox17 (green, endode-
mal; left), desmine (green, mesodermal; middle), and GFAP (green,
ectodermal; right). Nuclei were stained with DAPI (blue). (c)
Teratoma derived from rNP-iPS cells. Hematoxylin and eosin
staining of teratoma derived from rNP-iPS cells (#2 and #5).
Cells were transplanted into kidney capsule of three SCID mice.
A tumor developed from one injection site. Each image shows
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down/left), adipose tissue (mesodermal; up/middle), muscle tissue
(mesodermal; down/middle), epidermis (ectodermal; up/right)
and pigmented retinal epithelium (ectodermal; down/right).
Found at: doi:10.1371/journal.pone.0009838.s007 (0.64 MB TIF)
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